Aethlon Medical (AEMD) Equity Ratio (2011 - 2026)

Aethlon Medical's Equity Ratio history runs 16 years deep, the most recent figure standing at 0.77 for Q1 2026.

• For the quarter ending Q1 2026, Equity Ratio rose 10.83% year-over-year to 0.77; the trailing twelve-month figure through Mar 2026 stood at 0.77 (up 10.83% YoY), and the FY2026 full-year result was 0.77, up 10.83% from the prior year.
• Equity Ratio was 0.77 for Q1 2026 at Aethlon Medical, down from 0.83 in the prior quarter.
• Over the last five years, Equity Ratio for AEMD reached as high as 0.88 in Q1 2022 and fell as low as 0.65 in Q2 2025.
• Median Equity Ratio over the past 5 years was 0.78 (2025), compared with a mean of 0.78.
• Across the five-year window, Equity Ratio decreased 18.72% in 2024 and rose 25.44% in 2025, its largest moves.
• Over 5 years, Equity Ratio stood at 0.83 in 2022, then slipped by 12.53% to 0.73 in 2023, then decreased by 8.92% to 0.66 in 2024, then grew by 25.44% to 0.83 in 2025, then fell by 7.4% to 0.77 in 2026.
• Business Quant data shows AEMD's Equity Ratio at 0.77 in Q1 2026, 0.83 in Q4 2025, and 0.78 in Q3 2025.